Showing results (221-230 of 229) with videos related to
Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 229 results.
The Journal of Pathology|May 29, 2020
Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomasPaal W Wallace, Catleen Conrad, Sascha Brückmann, et al.Nature Communications|June 9, 2018
Alternative assembly of respiratory complex II connects energy stress to metabolic checkpointsAyenachew Bezawork-Geleta, He Wen, LanFeng Dong, et al.Iscience|April 17, 2025
Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclibYing Pang, Qi Li, Zach Sergi, et al.Journal of the National Cancer Institute|August 20, 2021
Germline SUCLG2 Variants in Patients With Pheochromocytoma and ParagangliomaKaterina Hadrava Vanova, Ying Pang, Linda Krobova, et al.Frontiers in Oncology|February 1, 2021
Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post ImmunotherapyGuangyang Yu, Madison K Butler, Abdalla Abdelmaksoud, et al.Development (Cambridge, England)|April 17, 2026
Targeting the cell membrane in established and emerging model organismsIrene Karapidaki, Mette Handberg-Thorsager, Tsuyoshi Momose, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Targeting the cell membrane in established and emerging model organismsIrene Karapidaki, Mette Handberg-Thorsager, Tsuyoshi Momose, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2021
Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade AstrocytomasJing Wu, Ying Yuan, Debra A Long Priel, et al.Advances in Therapy|March 22, 2021
Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 TrialYuqin Song, Hui Zhou, Huilai Zhang, et al.Pageof 23